Literature DB >> 11787809

Apoptosis in the genesis of cardiac rhythm disorders.

P Nerheim1, S C Krishnan, B Olshansky, K Shivkumar.   

Abstract

Programmed cell death has provided a potential pathogenetic mechanism that could play a role in several diseases of the cardiac conduction system and the myocardium that are clinically expressed as disorders of the cardiac rhythm (Fig. 4). Most of these studies have been descriptive. The exact nature of the triggers for apoptotic cell death is not well understood and is a subject of current investigation. Alterations in the architecture of the myocardium play an important role in the pathogenesis of ventricular arrhythmias that are responsible for a large proportion of sudden cardiac deaths. Although apoptosis is essential for normal development, excessive apoptosis resulting from pathological triggers may result in destruction of tissues and in the development of heart disease in which a fatal arrhythmic event may be a final common pathway. At present, the triggers for programmed cell death in disorders of the cardiac rhythm are not understood completely. Because diverse conditions trigger apoptosis, treatment strategies may have to be directed toward attenuating such triggers and, in some instances, toward modifying the process itself. If future therapies that can favorably modulate the apoptotic process in conditions such as dilated cardiomyopathy and postmyocardial infarction are developed, they will have the potential to prevent the pathologic alteration of myocardial architecture that is conducive to arrhythmogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11787809     DOI: 10.1016/s0733-8651(05)70201-0

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  12 in total

Review 1.  MicroRNA expression and function in cardiac ischemic injury.

Authors:  Shiyong Yu; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2010-06       Impact factor: 4.132

2.  Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome.

Authors:  C T Spencer; B J Byrne; M H Gewitz; S B Wechsler; A C Kao; E P Gerstenfeld; A D Merliss; M P Carboni; R M Bryant
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

3.  Evaluation of Tp-E Interval and Tp-E/QT Ratio in Patients with Aortic Stenosis.

Authors:  Çağrı Yayla; Murat Bilgin; Mehmet Kadri Akboğa; Kadriye Gayretli Yayla; Uğur Canpolat; Lale Dinç Asarcikli; Mehmet Doğan; Osman Turak; Serkan Çay; Özcan Özeke; Ahmet Akyel; Ekrem Yeter; Sinan Aydoğdu
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-08-05       Impact factor: 1.468

Review 4.  Cardiovascular effects of losartan and its relevant clinical application.

Authors:  Feichao Xu; Caiping Mao; Yali Hu; Can Rui; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

5.  Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.

Authors:  Cordula M Wolf; Libin Wang; Ronny Alcalai; Anne Pizard; Patrick G Burgon; Ferhaan Ahmad; Megan Sherwood; Dorothy M Branco; Hiroko Wakimoto; Glenn I Fishman; Vincent See; Colin L Stewart; David A Conner; Charles I Berul; Christine E Seidman; J G Seidman
Journal:  J Mol Cell Cardiol       Date:  2007-12-03       Impact factor: 5.000

6.  Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.

Authors:  Cinzia Forleo; Monica Carmosino; Nicoletta Resta; Alessandra Rampazzo; Rosanna Valecce; Sandro Sorrentino; Massimo Iacoviello; Francesco Pisani; Giuseppe Procino; Andrea Gerbino; Arnaldo Scardapane; Cristiano Simone; Martina Calore; Silvia Torretta; Maria Svelto; Stefano Favale
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

7.  The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis.

Authors:  Çağrı Yayla; Müçteba Enes Yayla; Kadriye Gayretli Yayla; Ufuk Ilgen; Mehmet Kadri Akboğa; Nurşen Düzgün
Journal:  Arch Rheumatol       Date:  2016-01-28       Impact factor: 1.472

Review 8.  MicroRNAs as a therapeutic target for cardiovascular diseases.

Authors:  Paras Kumar Mishra; Neetu Tyagi; Munish Kumar; Suresh C Tyagi
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310

9.  Identification and functional analysis of a new putative caveolin-3 variant found in a patient with sudden unexplained death.

Authors:  Vincenzo Lariccia; Annamaria Assunta Nasti; Federica Alessandrini; Mauro Pesaresi; Santo Gratteri; Adriano Tagliabracci; Salvatore Amoroso
Journal:  J Biomed Sci       Date:  2014-06-10       Impact factor: 8.410

10.  Gaseous signalling molecule SO2 via Hippo‑MST pathway to improve myocardial fibrosis of diabetic rats.

Authors:  Maojun Liu; Shengquan Liu; Wenting Tan; Fen Tang; Junrong Long; Zining Li; Biao Liang; Chun Chu; Jun Yang
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.